Luxana Biotech is established to contribute to medical treatment for suffering patients, .
Luxna Biotech has raised $1.7M in total funding. The most recent round was Series C. The last funding was announced in September 2024.
Luxna Biotech's investors include Mizuho Capital, Osaka University Venture Capital, Senshu Ikeda Capital, Japan Finance Corporation, Tohoku University Venture Partners.
Luxna Biotech is headquartered in Osaka, Japan.
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
Luxna Biotech is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Luxna Biotech — Funding & Investors." VCBacked, September 6, 2024, https://www.vcbacked.co/company/luxna-biotech. Accessed July 19, 2026.
VCBacked. (2024). Luxna Biotech — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/luxna-biotech
{{cite web |title=Luxna Biotech — Funding & Investors |url=https://www.vcbacked.co/company/luxna-biotech |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated